|
CCN2 |
cellular communication network factor 2 |
- YAP1- and WWTR1 (TAZ)-stimulated gene expression
- RUNX3 regulates YAP1-mediated transcription
|
|
|
|
CD82 |
CD82 molecule |
|
|
|
|
CTSG |
cathepsin G |
- Degradation of the extracellular matrix
- Activation of Matrix Metalloproteinases
- Metabolism of Angiotensinogen to Angiotensins
- Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
- Interleukin-1 processing
- Neutrophil degranulation
- Antimicrobial peptides
- Suppression of apoptosis
- Purinergic signaling in leishmaniasis infection
|
- Bis-Napthyl Beta-Ketophosphonic Acid
- 2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid
|
|
|
DAB1 |
DAB adaptor protein 1 |
- Reelin signalling pathway
|
|
|
|
DAB2 |
DAB adaptor protein 2 |
- Gap junction degradation
- Formation of annular gap junctions
- Cargo recognition for clathrin-mediated endocytosis
- Clathrin-mediated endocytosis
|
|
|
|
DLG4 |
discs large MAGUK scaffold protein 4 |
- Signaling by ERBB4
- Trafficking of AMPA receptors
- Unblocking of NMDA receptors, glutamate binding and activation
- Unblocking of NMDA receptors, glutamate binding and activation
- Ras activation upon Ca2+ influx through NMDA receptor
- NrCAM interactions
- Activation of Ca-permeable Kainate Receptor
- RHO GTPases activate CIT
- RAF/MAP kinase cascade
- LGI-ADAM interactions
- Neurexins and neuroligins
- Neurexins and neuroligins
- Synaptic adhesion-like molecules
- Assembly and cell surface presentation of NMDA receptors
- Negative regulation of NMDA receptor-mediated neuronal transmission
- Long-term potentiation
|
- Guanidine
- Guanosine-5'-Monophosphate
|
|
|
EGFR |
epidermal growth factor receptor |
- Signaling by ERBB2
- Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
- Signaling by ERBB4
- SHC1 events in ERBB2 signaling
- SHC1 events in ERBB2 signaling
- PLCG1 events in ERBB2 signaling
- PIP3 activates AKT signaling
- Signaling by EGFR
- GRB2 events in EGFR signaling
- GAB1 signalosome
- SHC1 events in EGFR signaling
- EGFR downregulation
- GRB2 events in ERBB2 signaling
- PI3K events in ERBB2 signaling
- EGFR interacts with phospholipase C-gamma
- EGFR Transactivation by Gastrin
- Constitutive Signaling by Aberrant PI3K in Cancer
- Signal transduction by L1
- Constitutive Signaling by EGFRvIII
- Inhibition of Signaling by Overexpressed EGFR
- RAF/MAP kinase cascade
- ERBB2 Regulates Cell Motility
- PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
- ERBB2 Activates PTK6 Signaling
- Cargo recognition for clathrin-mediated endocytosis
- Clathrin-mediated endocytosis
- PTK6 promotes HIF1A stabilization
- Downregulation of ERBB2 signaling
- TFAP2 (AP-2) family regulates transcription of growth factors and their receptors
- Extra-nuclear estrogen signaling
- NOTCH3 Activation and Transmission of Signal to the Nucleus
- HCMV Early Events
- Estrogen-dependent nuclear events downstream of ESR-membrane signaling
- Signaling by ERBB2 KD Mutants
- Signaling by ERBB2 ECD mutants
- Signaling by ERBB2 TMD/JMD mutants
|
- Cetuximab
- Lidocaine
- Gefitinib
- Erlotinib
- Lapatinib
- Panitumumab
- Alvocidib
- IGN311
- Matuzumab
- Vandetanib
- Rindopepimut
- Canertinib
- Pelitinib
- Varlitinib
- AV-412
- S-{3-[(4-ANILINOQUINAZOLIN-6-YL)AMINO]-3-OXOPROPYL}-L-CYSTEINE
- PD-168393
- Afatinib
- Osimertinib
- Necitumumab
- Foreskin keratinocyte (neonatal)
- Depatuxizumab mafodotin
- Icotinib
- Neratinib
- Dacomitinib
- Fostamatinib
- Zalutumumab
- Brigatinib
- Olmutinib
- Zanubrutinib
- Abivertinib
|
- Choriocarcinoma
- Gastric cancer
- Bladder cancer
- Oral cancer
- Glioma
- Laryngeal cancer
- Cervical cancer
- Esophageal cancer
|
|
ELANE |
elastase, neutrophil expressed |
- Collagen degradation
- Degradation of the extracellular matrix
- Degradation of the extracellular matrix
- Activation of Matrix Metalloproteinases
- Neutrophil degranulation
- Antimicrobial peptides
- Regulation of Complement cascade
|
- Alpha-1-proteinase inhibitor
- Filgrastim
- Mdl 101,146
- Freselestat
- Elafin
|
- Neutropenic disorders, including the following three diseases: Kostmann syndrome; Cyclic neutropenia; X-linked neutropenia/myelodysplasia
|
|
F8 |
coagulation factor VIII |
- Platelet degranulation
- Intrinsic Pathway of Fibrin Clot Formation
- Common Pathway of Fibrin Clot Formation
- Gamma carboxylation, hypusine formation and arylsulfatase activation
- COPII-mediated vesicle transport
- Cargo concentration in the ER
- Defective factor IX causes thrombophilia
- Defective F8 accelerates dissociation of the A2 domain
- Defective F8 cleavage by thrombin
- Defective F8 binding to von Willebrand factor
- Defective F8 binding to the cell membrane
- Defective cofactor function of FVIIIa variant
- Defective F8 secretion
- Defective F9 variant does not activate FX
- Defective F8 sulfation at Y1699
|
- Drotrecogin alfa
- Coagulation Factor IX (Recombinant)
- TB-402
- Thrombin
- Protein C
- Human thrombin
- Thrombin alfa
- Vonicog Alfa
- Von Willebrand Factor Human
- Anti-inhibitor coagulant complex
- Coagulation Factor IX Human
- Nonacog beta pegol
- Damoctocog alfa pegol
|
- Hemophilia; Hemophilia A (HEMA); Hemophilia B (HEMB); von Willebrand disease (VWD)
|
|
F9 |
coagulation factor IX |
- Extrinsic Pathway of Fibrin Clot Formation
- Intrinsic Pathway of Fibrin Clot Formation
- Gamma-carboxylation of protein precursors
- Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus
- Removal of aminoterminal propeptides from gamma-carboxylated proteins
- Defective factor IX causes thrombophilia
- Defective cofactor function of FVIIIa variant
- Defective F9 variant does not activate FX
- Defective F9 secretion
- Defective F9 activation
- Defective gamma-carboxylation of F9
|
- Antihemophilic factor, human recombinant
- Menadione
- TTP889
- Turoctocog alfa
- Kappadione
- Coagulation factor VII human
- Antihemophilic factor human
- Emicizumab
- Lonoctocog alfa
- Moroctocog alfa
- Turoctocog alfa pegol
|
- Hemophilia; Hemophilia A (HEMA); Hemophilia B (HEMB); von Willebrand disease (VWD)
|
|
FURIN |
furin, paired basic amino acid cleaving enzyme |
- Signaling by NODAL
- Collagen degradation
- Collagen degradation
- Elastic fibre formation
- Activation of Matrix Metalloproteinases
- Removal of aminoterminal propeptides from gamma-carboxylated proteins
- NGF processing
- Synthesis and processing of ENV and VPU
- Signaling by PDGF
- Pre-NOTCH Processing in Golgi
- TGF-beta receptor signaling activates SMADs
- Uptake and function of anthrax toxins
- Formation of the cornified envelope
- Assembly of active LPL and LIPC lipase complexes
- CD163 mediating an anti-inflammatory response
- Potential therapeutics for SARS
- Attachment and Entry
- Amyloid fiber formation
|
|
|
|
GIPC1 |
GIPC PDZ domain containing family member 1 |
|
|
|
|
GTPBP1 |
GTP binding protein 1 |
|
|
|
|
GULP1 |
GULP PTB domain containing engulfment adaptor 1 |
|
|
|
|
HNRNPDL |
heterogeneous nuclear ribonucleoprotein D like |
- Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation
|
|
|
|
HSP90B1 |
heat shock protein 90 beta family member 1 |
- Trafficking and processing of endosomal TLR
- Scavenging by Class A Receptors
- Scavenging by Class A Receptors
- ATF6 (ATF6-alpha) activates chaperone genes
- Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
- Interleukin-4 and Interleukin-13 signaling
- Post-translational protein phosphorylation
|
- Rifabutin
- 2-Chlorodideoxyadenosine
- Geldanamycin
- Diglyme
- N-Ethyl-5'-Carboxamido Adenosine
- Radicicol
- METHYL 3-CHLORO-2-{3-[(2,5-DIHYDROXY-4-METHOXYPHENYL)AMINO]-3-OXOPROPYL}-4,6-DIHYDROXYBENZOATE
- 2-(3-AMINO-2,5,6-TRIMETHOXYPHENYL)ETHYL 5-CHLORO-2,4-DIHYDROXYBENZOATE
- Copper
|
|
|
ITGB1BP1 |
integrin subunit beta 1 binding protein 1 |
|
|
|
|
KAT5 |
lysine acetyltransferase 5 |
- Formation of the beta-catenin:TCF transactivating complex
- Formation of the beta-catenin:TCF transactivating complex
- DNA Damage/Telomere Stress Induced Senescence
- HATs acetylate histones
- HDR through Single Strand Annealing (SSA)
- HDR through Homologous Recombination (HRR)
- Sensing of DNA Double Strand Breaks
- Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)
- Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
- Resolution of D-loop Structures through Holliday Junction Intermediates
- Nonhomologous End-Joining (NHEJ)
- Homologous DNA Pairing and Strand Exchange
- Processing of DNA double-strand break ends
- Presynaptic phase of homologous DNA pairing and strand exchange
- Regulation of TP53 Activity through Phosphorylation
- G2/M DNA damage checkpoint
- Estrogen-dependent gene expression
|
- Coenzyme A
- S-Acetyl-Cysteine
|
|
|
LIPC |
lipase C, hepatic type |
- Assembly of active LPL and LIPC lipase complexes
- Chylomicron clearance
|
|
|
|
LPL |
lipoprotein lipase |
- Transcriptional regulation of white adipocyte differentiation
- Assembly of active LPL and LIPC lipase complexes
- Chylomicron remodeling
- Retinoid metabolism and transport
|
- Tyloxapol
- Omega-3-carboxylic acids
- Glycyrrhizic acid
|
- Hyperlipoproteinemia, type I
|